405 related articles for article (PubMed ID: 17716993)
1. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
[TBL] [Abstract][Full Text] [Related]
4. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
Voon HP; Wardan H; Vadolas J
Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
[TBL] [Abstract][Full Text] [Related]
6. Beta globin gene inhibition by antisense RNA transcripts.
Xu L; Ferry AE; Monteiro C; Pace BS
Gene Ther; 2000 Mar; 7(5):438-44. PubMed ID: 10694826
[TBL] [Abstract][Full Text] [Related]
7. Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors.
Xie SY; Li W; Ren ZR; Huang SZ; Zeng F; Zeng YT
Int J Hematol; 2011 Mar; 93(3):301-310. PubMed ID: 21369857
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
9. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M
Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546
[TBL] [Abstract][Full Text] [Related]
11. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
Gu X; Gong L; Zhang W
Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
13. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
14. [Update on RNA splicing repair: applications to beta thalassemia and other perspectives].
Labie D; Kaplan JC
Med Sci (Paris); 2010 Jan; 26(1):38-41. PubMed ID: 20132773
[No Abstract] [Full Text] [Related]
15. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
16. Current status of globin gene therapy for the treatment of beta-thalassaemia.
Lisowski L; Sadelain M
Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
Bank A; Dorazio R; Leboulch P
Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
[TBL] [Abstract][Full Text] [Related]
19. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]